Increased Survivorship and Altered Cytokine Profile from Treatment of Influenza A H1N1-Infected Mice with Ekybion: A Drug Complex of Natural Extracts and Inorganic Compounds
Figure 1
In vitro efficacy of Ekybion. Inhibition of influenza A in MDCK cells was performed by treating cells infected with 0.01 MOI influenza A/PR/8/43 H1N1 begnining at the indicated times pre- or postinfection and measuring virus titer by hemagglutination assay at either 24 (grey bars) or 48 (black bars) hours postinfection. (, by Two-Way ANOVA with Bonferroni posttests on Log2 transformed data).
